₹ 19,576.00
152.00 (0.78%)
N
Neuland Laboratories
₹ 19,576.00
Neuland Laboratories Share Price Today
Neuland Laboratories (NEULANDLAB) share price is trading at ₹19,576.00 on the NSE as of November 4, 2026 at 03:29 PM, up by 0.78% from its previous close of ₹19,424.00. In todays trading session NEULANDLAB reached a high of 19,850.00 and low of 18,501.00. The average traded price for today is 19,531.97. The 50 DMA stands at 21,591.78 and 200 DMA is at 17,443.77. Looking at intraday trend, the stock is moving sideways.
Stock Overview
- Symbol : NEULANDLAB
- Open : ₹18,501.00
- Previous Close : ₹19,424.00
- Day's Range : ₹18,501.00 – ₹19,850.00
- 52-Week Range : ₹11,500.00 – ₹24,225.00
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
NEULANDLAB Stock Performance
Markets Today
High
19,850.00
Low
18,501.00
Open at
18,501.00
Prev Close
19,424.00
Volumes
1,48,314
Avg Price
19,531.97
Lower Circuit
15,661.00
Upper Circuit
23,491.00
Last Traded Details
Quantity
1
Time
15:29:56
Price Movement
Historical Performance
3 M High
24,225.00
3 M Low
18,120.00
1 Yr High
24,225.00
1 Yr Low
11,500.00
3 Yr High
24,225.00
3 Yr Low
3,845.00
5 Yr High
24,225.00
5 Yr Low
967.00
1-Year Performance
NEULANDLAB Pros and Cons
Development revenue grows from ₹14 Cr to ₹418 Cr from Q1 FY26 to Q1 2026-27, highlighting a successful pipeline push.
EBITDA margin rises from 14% to 35.5% from Q1 FY26 to Q1 2026-27, confirming strong pricing power.
Working capital days of sale fall from 145 days to 84 days from Q1 FY26 to Q1 2026-27, showing faster cash conversion.
Top 5 customer concentration drops from 47% to 40% from Q1 FY26 to Q1 2026-27, reducing client dependency.
ROCE improves from 5.1% to 35.8% from Q1 FY26 to Q1 2026-27, reflecting much better capital efficiency.
Commercial revenue falls from ₹488 Cr to ₹20 Cr from Q4 FY26 to Q1 2026-27, signaling a temporary disruption in mature product sales.
Specialty revenue mix drops from 44% to 8% from Q1 FY26 to Q1 2026-27, indicating a major shift away from this segment.
Top 5 products concentration rises from 85% to 89% from Q1 FY26 to Q1 2026-27, keeping product focus narrow.
Prime revenue mix declines from 32% to 18% from Q1 FY26 to Q1 2026-27, showing reduced contribution from this category.
NEULANDLAB Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 4 analysts
Buy
100%
Hold
0%
Sell
0%
Get forecast for Price, ROA & ROE based on analyst ratings.
NEULANDLAB Share Price History
NEULANDLAB Fundamentals
Company Valuation
Market Cap (₹ Cr.)
25,116
PE Ratio
50.10
PB Ratio
13.31
Dividend Yield
0.18%
ROE
19.42%
ROCE
23.11%
Book Value (₹)
1,460.31
Face Value (₹)
10.00
Analyse NEULANDLAB with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 32.64% | 32.63% | 32.63% | 32.62% | 32.26% |
| Domestic Institutional Investors (DII) | 13.54% | 14.71% | 15.84% | 16.51% | 16.26% |
| Foreign Institutional Investors (FII) | 20.60% | 20.90% | 20.46% | 21.08% | 21.93% |
| Public Investors | 24.72% | 24.31% | 23.84% | 22.88% | 22.47% |
| Government | 0.40% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Neuland Laboratories Return Calculator
Note: Past profits do not guarantee future returns.
NEULANDLAB Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
NEULANDLAB Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for NEULANDLAB
Margin on NEULANDLAB
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
NEULANDLAB Financials Summary
In Crores
NEULANDLAB Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check NEULANDLAB latest Company Filings, Investor Presentation & Conference Call details.
NEULANDLAB Revenue Growth
All values are in Crores
Revenue
Profit
Loss
NEULANDLAB Similar Stocks
FAQs on NEULANDLAB
What is the share price of Neuland Laboratories?
What is the 52W high and 52W low of Neuland Laboratories?
What is the return on Neuland Laboratories share?
- Past 1 year: 14.09%
- Past 3 years: 406.30%
- Past 5 years: 1,084.70%
What is the PE and PB Ratio of Neuland Laboratories?
What is the EPS of Neuland Laboratories?
What is the shareholding pattern of Neuland Laboratories?
- DIIs - 16.26%
- FII - 21.93%
- Promoters - 32.26%
- Public Investors 22.47%
- Goverenment - 0.00%
How to buy Neuland Laboratories shares online?
How to buy Neuland Laboratories shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Neuland Laboratories share
- Tap on “Buy”
